Literature DB >> 26187769

Personal Hygiene and Vulvovaginitis in Prepubertal Children.

Fatıma Cemek1, Dursun Odabaş2, Ünal Şenel3, Ayşe Tuba Kocaman3.   

Abstract

STUDY
OBJECTIVE: To determine and compare clinical and microbiological features of vulvovaginitis in prepubertal girls. Vulvovaginitis is the most common gynecological problem of childhood. DESIGN, SETTING, PARTICIPANTS, INTERVENTIONS, AND MAIN OUTCOME MEASURES: This study involved 45 girls from 2-12 (5.38 ± 2.9) years old; and 26 girls from 3-12 (5.72 ± 3.1) years old as a control group. Anamnesis and physical examination were followed by vaginal smear, urine culture, and stool analyses from both groups, and the personal hygiene status and education level of the mother were determined.
RESULTS: The most common symptoms among the patients were vaginal discharge (44.4%, vulvar erythema (37.8%), and vaginal itch (24.4%). Microorganisms, isolated from vaginal smears, were detected in 48.9% of the patients. Escherichia coli was shown in the urine culture of 3 patients with vulvovaginitis (6.70%). In microscopic stool analysis parasites were detected (45.9%). We found some relevant personal hygiene factors, such as wiping back to front (42.9%), cleaning by herself after defecation (89.3%), using toilet paper (60.7%) and wet wipes (21.4%), and bathing standing (14.3%) and sitting (46.4%) among patients. The questionnaire also showed that the children wore tight clothing (35.7%).
CONCLUSION: Our findings suggest that vulvovaginitis in prepubertal girls is related not only to microorganisms but also poor personal hygiene, the educational status of mothers, and specific irritants.
Copyright © 2015 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Personal hygiene; Prepubertal girls; Vaginal discharge; Vulvovaginitis

Mesh:

Year:  2015        PMID: 26187769     DOI: 10.1016/j.jpag.2015.07.002

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  5 in total

1.  Microbiological findings in prepubertal and pubertal girls with vulvovaginitis.

Authors:  Stavroula Baka; Stiliani Demeridou; George Kaparos; Konstantinos Tsoutsouras; Sotirios Touloumakos; Maria Dagre; Sofia Meretaki; Anthia Chasiakou; Vasiliki Koumaki; Athanasios Tsakris
Journal:  Eur J Pediatr       Date:  2022-09-26       Impact factor: 3.860

2.  Menstrual cups and sanitary pads to reduce school attrition, and sexually transmitted and reproductive tract infections: a cluster randomised controlled feasibility study in rural Western Kenya.

Authors:  Penelope A Phillips-Howard; Elizabeth Nyothach; Feiko O Ter Kuile; Jackton Omoto; Duolao Wang; Clement Zeh; Clayton Onyango; Linda Mason; Kelly T Alexander; Frank O Odhiambo; Alie Eleveld; Aisha Mohammed; Anna M van Eijk; Rhiannon Tudor Edwards; John Vulule; Brian Faragher; Kayla F Laserson
Journal:  BMJ Open       Date:  2016-11-23       Impact factor: 2.692

3.  Examining the safety of menstrual cups among rural primary school girls in western Kenya: observational studies nested in a randomised controlled feasibility study.

Authors:  Jane Juma; Elizabeth Nyothach; Kayla F Laserson; Clifford Oduor; Lilian Arita; Caroline Ouma; Kelvin Oruko; Jackton Omoto; Linda Mason; Kelly T Alexander; Barry Fields; Clayton Onyango; Penelope A Phillips-Howard
Journal:  BMJ Open       Date:  2017-05-04       Impact factor: 2.692

4.  Efficacy, acceptability and tolerability of Zelesse® for the treatment of non-specific vulvovaginitis in paediatric patients: The NINESSE Study.

Authors:  Fátima García; Carmen-Amparo Rodríguez; María-Lourdes Palomo; Pere Català; Santiago Fernández; Ibone Huerta; Syra Velasco; Concepción Nieto
Journal:  J Int Med Res       Date:  2018-06-07       Impact factor: 1.671

5.  STROBE-sequencing analysis of the vaginal microecology of 4- to 6-year-old girls in Southwest China.

Authors:  Yiduo Zhang; Ting Liu; Jingying Lin; Fan Yu; Zhengqiang Hu
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.